In breast cancer, among the most enriched pathways is peroxisomal transport genes, including the peroxisomal transporters ABCD1, ABCD2, and ABCD3, which transport fatty acids and acyl-CoAs and have been shown to be markers of tumor progression and response to therapy [36]. Here, ABCD2 is linked to neoplasm.